HK1256827A1 - 與糖尿病前期、糖尿病及糖尿病相關病症相關的生物標記 - Google Patents
與糖尿病前期、糖尿病及糖尿病相關病症相關的生物標記Info
- Publication number
- HK1256827A1 HK1256827A1 HK18115912.3A HK18115912A HK1256827A1 HK 1256827 A1 HK1256827 A1 HK 1256827A1 HK 18115912 A HK18115912 A HK 18115912A HK 1256827 A1 HK1256827 A1 HK 1256827A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- diabetes
- related conditions
- biomarkers associated
- biomarkers
- diabetes related
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90212—Oxidoreductases (1.) acting on a sulfur group of donors (1.8)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/908—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2010904249A AU2010904249A0 (en) | 2010-09-21 | Biomarkers associated with pre-diabetes,diabetes and diabetes related conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1256827A1 true HK1256827A1 (zh) | 2019-10-04 |
Family
ID=45873304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18115912.3A HK1256827A1 (zh) | 2010-09-21 | 2018-12-12 | 與糖尿病前期、糖尿病及糖尿病相關病症相關的生物標記 |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US20130177544A1 (zh) |
| EP (3) | EP2619592A4 (zh) |
| JP (2) | JP6271250B2 (zh) |
| CN (2) | CN103299192B (zh) |
| AU (2) | AU2011305050B2 (zh) |
| BR (1) | BR112013006764B1 (zh) |
| CA (1) | CA2811654C (zh) |
| ES (2) | ES2665910T3 (zh) |
| HK (1) | HK1256827A1 (zh) |
| RU (1) | RU2596486C2 (zh) |
| SG (1) | SG188527A1 (zh) |
| WO (1) | WO2012037603A1 (zh) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2619592A4 (en) * | 2010-09-21 | 2014-05-07 | Proteomics Internat Pty Ltd | BIOMARKERS ASSOCIATED WITH PRE DIABETES, DIABETES AND DISORDERS ASSOCIATED WITH DIABETES |
| US9928345B2 (en) | 2012-06-08 | 2018-03-27 | Liposciences, Inc. | Multiple-marker risk parameters predictive of conversion to diabetes |
| US9361429B2 (en) | 2012-06-08 | 2016-06-07 | Liposcience, Inc. | Multi-parameter diabetes risk evaluations |
| CN104737020B (zh) * | 2012-08-30 | 2016-08-17 | 希森美康株式会社 | 早期肾障碍的评价指标和其测定方法 |
| CA2941554A1 (en) | 2013-03-14 | 2014-10-02 | Otraces Inc. | A method for improving disease diagnosis using measured analytes |
| CN103473569A (zh) * | 2013-09-22 | 2013-12-25 | 江苏美伦影像系统有限公司 | 基于svm的医学影像分类方法 |
| WO2015056619A1 (ja) * | 2013-10-16 | 2015-04-23 | 日本水産株式会社 | ペプチド又はその酸付加塩、飲食品、及び糖尿病予防等の組成物 |
| JP6759104B2 (ja) | 2014-04-04 | 2020-09-23 | メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ | 精密分子質量を用いた免疫グロブリンのアイソタイピング |
| US11209439B2 (en) | 2015-09-24 | 2021-12-28 | Mayo Foundation For Medical Education And Research | Identification of immunoglobulin free light chains by mass spectrometry |
| EP3405896A4 (en) | 2016-01-22 | 2019-09-25 | Otraces Inc. | SYSTEMS AND METHODS FOR ENHANCING DIAGNOSIS OF DISEASE |
| CN109863395B (zh) | 2016-09-07 | 2023-05-23 | 梅约医学教育与研究基金会 | 分子量法鉴定和监测裂解免疫球蛋白 |
| US11313861B2 (en) | 2016-11-11 | 2022-04-26 | Otsuka Pharmaceutical Co., Ltd. | Method of evaluating hepatic glucose uptake capacity |
| PL3358355T3 (pl) * | 2017-02-04 | 2024-04-08 | Warszawski Uniwersytet Medyczny | Zastosowanie surowiczych peroksyredoksyn dwucysteinowych (2-Cys-PRDX) jako biomarkerów przewlekłej choroby nerek (PChN, ang. CKD) takiej jak toczniowe zapalenie nerek (LN), nefropatia IgA (IgAN) i autosomalna dominująca wielotorbielowatość nerek (ADPKD) użytecznych do diagnozowania tych chorób i sposoby różnicowania tych chorób |
| CN106645757B (zh) * | 2017-03-13 | 2019-01-15 | 新疆医科大学 | 一种诊断早发糖尿病mody的血清蛋白标志物组及其应用 |
| CN107144620A (zh) * | 2017-03-31 | 2017-09-08 | 兰州百源基因技术有限公司 | 糖尿病肾病检测标志物 |
| JP7337701B2 (ja) * | 2017-03-31 | 2023-09-04 | クエスト ダイアグノスティックス インヴェストメンツ エルエルシー | インスリン及びｃ－ペプチドの定量の方法 |
| CN108732253A (zh) * | 2017-04-14 | 2018-11-02 | 杭州量康科技有限公司 | 用于血清蛋白质定量测定的肽段组合物及测定方法 |
| EP3681528A4 (en) | 2017-09-13 | 2021-07-21 | Mayo Foundation for Medical Education and Research | IDENTIFICATION AND MONITORING OF THE APOPTOSIS INHIBITOR OF MACROPHAGES |
| RU2687256C1 (ru) * | 2018-03-26 | 2019-05-08 | Федеральное Государственное бюджетное образовательное учреждение высшего образования Дагестанский государственный медицинский университет Министерства здравоохранения Российской Федерации Даггосмедуниверситет | Способ персонализированного лечения хронической болезни почек у больных с диабетической нефропатией |
| US20210208165A1 (en) * | 2018-06-21 | 2021-07-08 | China Medical University | Protein biomarkers for nephropathy and applications thereof |
| EA202190355A1 (ru) * | 2018-08-08 | 2021-05-25 | Ридженерон Фармасьютикалз, Инк. | Применение жх-мс/мс для количественного определения белковых биомаркеров |
| CN110286234B (zh) * | 2019-07-02 | 2023-03-24 | 安肽和(杭州)医疗科技有限公司 | 尿液中妊娠糖尿病的蛋白质标志物及其在早期诊断中的用途 |
| KR20220123236A (ko) * | 2020-01-10 | 2022-09-06 | 소마로직 오퍼레이팅 컴퍼니, 인코포레이티드 | 손상된 당내성 결정 방법 |
| CN111876479A (zh) * | 2020-06-29 | 2020-11-03 | 中国人民解放军总医院 | 基于尿沉渣特定微小rna无创鉴别诊断糖尿病肾病/非糖尿病性肾病方面的应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100640201B1 (ko) * | 2004-12-07 | 2006-10-30 | (주) 대홍기업 | 히트파이프가 설치된 도어 조립체 및 이 도어 조립체를채택한 김치저장고 |
| JP2008538812A (ja) * | 2005-04-11 | 2008-11-06 | アストラゼネカ アクチボラグ | 方法 |
| JP2008541062A (ja) * | 2005-05-05 | 2008-11-20 | ファイブローゲン、インコーポレーテッド | 糖尿病血管合併症の診断マーカー |
| WO2007028636A1 (en) * | 2005-09-09 | 2007-03-15 | Medizinische Universität Innsbruck | Method for predicting the progression of chronic kidney disease by measuring apolipoprotein a-iv |
| US20070218519A1 (en) * | 2005-10-11 | 2007-09-20 | Tethys Bioscience, Inc. | Diabetes-associated markers and methods of use thereof |
| WO2007056587A2 (en) * | 2005-11-09 | 2007-05-18 | The General Hospital Corporation | Predicting diabetic nephropathy (dn) |
| AU2006336091C1 (en) * | 2006-01-20 | 2014-01-16 | Mosaiques Diagnostics And Therapeutics Ag | Method and markers for the diagnosis of renal diseases |
| SG173310A1 (en) * | 2006-03-23 | 2011-08-29 | Emelita De Guzman Breyer | Apolipoprotein fingerprinting technique |
| US7901885B2 (en) * | 2006-05-09 | 2011-03-08 | Dsm Ip Assets B.V. | Genes and markers in type 2 diabetes and obesity |
| KR100792630B1 (ko) * | 2006-07-05 | 2008-01-09 | 고려대학교 산학협력단 | 당뇨병성 신증 진단용 바이오 마커 |
| WO2008031051A2 (en) * | 2006-09-08 | 2008-03-13 | United Therapeutics Corporation | Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers |
| WO2009039421A1 (en) * | 2007-09-20 | 2009-03-26 | University Of Louisville Research Foundation, Inc. | Peptide biomarkers predictive of renal function decline and kidney disease |
| WO2009103312A1 (en) * | 2008-02-19 | 2009-08-27 | Ludwig-Maximilians-Universität | Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases |
| AU2009234444A1 (en) * | 2008-04-11 | 2009-10-15 | China Synthetic Rubber Corporation | Methods, agents and kits for the detection of cancer |
| US8673644B2 (en) * | 2008-05-13 | 2014-03-18 | Battelle Memorial Institute | Serum markers for type II diabetes mellitus |
| US20100136540A1 (en) * | 2008-06-13 | 2010-06-03 | Pavel Hamet | Methods and compositions for characterizing patients for clinical outcome trials |
| EP2307050A4 (en) * | 2008-07-04 | 2012-07-25 | Ono Pharmaceutical Co | USE OF A EFFECTIVENESS MARKER TO OPTIMIZE THE THERAPEUTIC EFFECTIVENESS OF AN ANTI-HUMAN PD-1 ANTIBODY ON CANCERS |
| US20110311650A1 (en) * | 2008-07-07 | 2011-12-22 | Thomas Wang | Multiplexed biomarkers of insulin resistance |
| US8735443B2 (en) * | 2008-10-21 | 2014-05-27 | Kuwait University | Method of treating diabetes-related vascular complications |
| AU2010208394A1 (en) * | 2009-01-27 | 2011-09-08 | Hologic, Inc. | Biomarkers for detection of neonatal sepsis in biological fluid |
| CA2748937C (en) * | 2009-01-28 | 2016-07-19 | Industrial Technology Research Institute | Urine and serum biomarkers associated with diabetic nephropathy |
| EP2510361A4 (en) * | 2009-12-11 | 2013-07-17 | Purdue Research Foundation | DETECTION OF OXIDIZED POLYPEPTIDES |
| JPWO2011145725A1 (ja) * | 2010-05-20 | 2013-07-22 | 宮崎 徹 | Ａｉｍ関連疾患の診断方法及び診断用キット |
| EP2619592A4 (en) * | 2010-09-21 | 2014-05-07 | Proteomics Internat Pty Ltd | BIOMARKERS ASSOCIATED WITH PRE DIABETES, DIABETES AND DISORDERS ASSOCIATED WITH DIABETES |
-
2011
- 2011-09-20 EP EP11826214.6A patent/EP2619592A4/en not_active Ceased
- 2011-09-20 JP JP2013528474A patent/JP6271250B2/ja active Active
- 2011-09-20 WO PCT/AU2011/001212 patent/WO2012037603A1/en active Application Filing
- 2011-09-20 AU AU2011305050A patent/AU2011305050B2/en active Active
- 2011-09-20 BR BR112013006764-0A patent/BR112013006764B1/pt active IP Right Grant
- 2011-09-20 RU RU2013113927/15A patent/RU2596486C2/ru active
- 2011-09-20 ES ES16194985.4T patent/ES2665910T3/es active Active
- 2011-09-20 EP EP16194985.4A patent/EP3151012B1/en active Active
- 2011-09-20 US US13/824,359 patent/US20130177544A1/en not_active Abandoned
- 2011-09-20 ES ES18155797T patent/ES2928585T3/es active Active
- 2011-09-20 CA CA2811654A patent/CA2811654C/en active Active
- 2011-09-20 EP EP18155797.6A patent/EP3343226B1/en active Active
- 2011-09-20 CN CN201180053583.9A patent/CN103299192B/zh active Active
- 2011-09-20 CN CN201610302678.4A patent/CN105974123A/zh active Pending
- 2011-09-20 SG SG2013018593A patent/SG188527A1/en unknown
-
2014
- 2014-05-14 US US14/277,371 patent/US9146243B2/en active Active
-
2015
- 2015-04-29 AU AU2015202230A patent/AU2015202230B2/en active Active
- 2015-08-24 US US14/833,199 patent/US9733259B2/en active Active
-
2017
- 2017-06-26 US US15/632,753 patent/US10191067B2/en active Active
- 2017-07-12 JP JP2017136403A patent/JP2017223682A/ja active Pending
-
2018
- 2018-12-12 HK HK18115912.3A patent/HK1256827A1/zh unknown
- 2018-12-13 US US16/218,777 patent/US20190107546A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1256827A1 (zh) | 與糖尿病前期、糖尿病及糖尿病相關病症相關的生物標記 | |
| EP2553835A4 (en) | Terminal equipment with improved service availability | |
| EP2470817A4 (en) | Press-connect fitting with improved grab-ring function | |
| EP2414535A4 (en) | BIOMARKERS RELATED TO INSULIN RESISTANCE AND METHODS OF USE | |
| EP2443259A4 (en) | BIOMARKERS FOR AUTISM AND USES THEREOF | |
| EP2611325B8 (de) | Schaftanordnung für schuhwerk sowie schuhwerk damit | |
| HK1202511A1 (zh) | 樞轉配置、廂頂元件和電梯 | |
| EP2646645A4 (en) | Tapered thread configuration with improved durability | |
| PL2525746T3 (pl) | Wkładka ze zintegrowaną elektrodą | |
| PL2384901T5 (pl) | Dokument wartościowy z wybraniem | |
| GB201021502D0 (en) | Biomarkers | |
| GB201008340D0 (en) | Biomarkers | |
| ZA201409006B (en) | Diabetes biomarkers | |
| TWM388085U (en) | Keyboard structure with backlighting | |
| GB201018056D0 (en) | Biomarkers | |
| EP2625435A4 (en) | JOINT WITH LOCKING ELEMENT | |
| GB201005561D0 (en) | Biomarkers | |
| GB201001444D0 (en) | Biomarkers | |
| EP2615697A4 (en) | TO A LEVER-MOUNTED PLUG AND CONNECTOR WITH THE PLUG MOUNTED ON A LEVER | |
| EP2598522A4 (en) | RECOMBINANT LECTINES, LECTINES WITH MODIFIED BINDING SITE AND USES THEREOF | |
| EP2554994A4 (en) | BIOMARKERS | |
| GB201010316D0 (en) | Biomarkers | |
| EP2391653B8 (en) | Biomarkers associated with nephropathy | |
| GB201001419D0 (en) | Biomarkers | |
| AU2010904249A0 (en) | Biomarkers associated with pre-diabetes,diabetes and diabetes related conditions |